The Effect of Catheter-Associated Infection Control Training
NCT ID: NCT05670119
Last Updated: 2023-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2023-01-25
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is there a difference between the knowledge and attitude levels of surgical nurses receiving and not receiving catheter-related infection control training on preventing peripheral and central catheter-related bloodstream infections?
* Is there a difference between the knowledge and attitude levels of surgical nurses receiving and not receiving catheter-related infection control training to prevent catheter-related urinary tract infections?
The main tasks that the participants will be asked to do will be explained and their consent will be obtained. The two research groups will be compared.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Nurses in the intervention group will be given face-to-face training on evidence-based catheter-related infection control measures. The content of the training program will also be given to the participants as written material (brochure). The training will take an average of 30 minutes. After the data collection forms are applied to the participants in the intervention group (pre-test), evidence-based training on catheter-related infection control measures will be conducted. The forms will be applied again immediately after the training (post-test) to measure the knowledge level of nurses and three months after the training (post-test) to measure the level of attitude.
Structured Training
Structured catheter-related infection control training was prepared by using evidence-based information and receiving 10 expert opinions. This training will be given to the participants with a face-to-face PowerPoint presentation by the infection control nurse (researcher) and will also be presented as written material.
Control Group
Routine in-service training practices will be given to the control group. Data collection forms will be applied to the participants in the control group at the same time as the intervention group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured Training
Structured catheter-related infection control training was prepared by using evidence-based information and receiving 10 expert opinions. This training will be given to the participants with a face-to-face PowerPoint presentation by the infection control nurse (researcher) and will also be presented as written material.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Working in the surgical unit
* Agreeing to participate in the research
Exclusion Criteria
* Not filling out the questionnaire
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif Gezginci
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Habibe Filiz Akdemir, RN
Role: PRINCIPAL_INVESTIGATOR
Saglik Bilimleri Universitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Habibe Filiz Akdemir
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Habibe Filiz Akdemir
Role: primary
Elif Gezginci
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Bakan AB, Arli SK. Development of the peripheral and central venous catheter-related bloodstream infection prevention knowledge and attitudes scale. Nurs Crit Care. 2021 Jan;26(1):35-41. doi: 10.1111/nicc.12422. Epub 2019 Feb 28.
Suha BK, Karagozoglu S. The Effect of a Guide Based Application Bundle on the Catheter-Related Infection. Florence Nightingale Hemsire Derg. 2019 Oct 1;27(3):222-230. doi: 10.5152/FNJN.2019.426870. eCollection 2019 Oct.
Related Links
Access external resources that provide additional context or updates about the study.
Guideline for Hand Hygiene in Health-Care Settings Recommendation of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.
Bloodstream infection event (Central line-associated bloodstream ınfection and non-central line associated bloodstream infection).
Healthcare associated infections acquired in intensive care units - annual epidemiological report for 2015. Stockholm (Sweden): European Centre for Disease Prevention and Control.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-245
Identifier Type: -
Identifier Source: org_study_id